Lung Transplant Outcome From Selected Older Donors (& GE;70 Years) Equals Younger Donors (<70 Years) A Propensity-matched Analysis

Objective:To describe our experience with lung transplantation (LTx) from donors & GE;70 years and compare short and long-term outcomes to a propensity-matched cohort of donors Background:Although extended-criteria donors have been widely used to enlarge the donor pool, the experience with LTx from older donors (& GE;70 years) remains limited. Methods:All single-center bilateral LTx between 2010 and 2020 were retrospectively analyzed. Matching (1:1) was performed for the donor (type, sex, smoking history, x-ray abnormalities, partial pressure of oxygen/fraction of inspired oxygen ratio, and time on ventilator) and recipient characteristics (age, sex, LTx indication, perioperative extracorporeal life support, and cytomegalovirus mismatch). Primary graft dysfunction grade-3, 5-year patient, and chronic lung allograft dysfunction-free survival were analyzed. Results:Out of 647 bilateral LTx, 69 were performed from donors & GE;70 years. The mean age in the older donor cohort was 74 years (range: 70-84 years) versus 49 years (range: 12-69 years) in the matched younger group. No significant differences were observed in the length of ventilatory support, intensive care unit, or hospital stay. Primary graft dysfunction-3 was 26% in the older group versus 29% in younger donor recipients (P = 0.85). Reintervention rate was comparable (29% vs 16%; P = 0.10). Follow-up bronchoscopy revealed no difference in bronchial anastomotic complications (P = 1.00). Five-year patient and chronic lung allograft dysfunction-free survivals were 73.6% versus 73.1% (P = 0.72) and 51.5% versus 59.2% (P = 0.41), respectively. Conclusions:LTx from selected donors & GE;70 years is feasible and safe, yielding comparable short and long-term outcomes in a propensity-matched analysis with younger donors (<70 years).

Automated summary

This study retrospectively analyzed single-center bilateral lung transplantations performed between 2010 and 2020. The results showed that lung transplantation from donors aged ≥70 years is feasible and safe, with comparable short and long-term outcomes to transplantation from younger donors.